A method for reproducible measurements of serum BDNF: comparison of the performance of six commercial assays
Brain-Derived Neurotrophic Factor (BDNF) has attracted increasing interest as potential biomarker to support the diagnosis or monitor the efficacy of therapies in brain disorders. Circulating BDNF can be measured in serum, plasma or whole blood. However, the use of BDNF as biomarker is limited by th...
Main Authors: | Polacchini, A, Metelli, G, Francavilla, R, Baj, G, Florean, M, Mascaretti, L, Tongiorgi, E |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer Nature
2015
|
Similar Items
-
Distinct CCL2, CCL5, CCL11, CCL27, IL-17, IL-6, BDNF serum profiles correlate to different job-stress outcomes
by: Alessio Polacchini, et al.
Published: (2018-02-01) -
Localization of BDNF mRNA with the Huntington's disease protein in rat brain
by: Chao Moses V, et al.
Published: (2010-05-01) -
Chemical LTP induces confinement of BDNF mRNA under dendritic spines and BDNF protein accumulation inside the spines
by: Giorgia Bimbi, et al.
Published: (2024-02-01) -
Distinct role of 5′UTR sequences in dendritic trafficking of BDNF mRNA: additional mechanisms for the BDNF splice variants spatial code
by: Andrea Colliva, et al.
Published: (2021-01-01) -
Comparison of commercial ELISA assays for quantification of corticosterone in serum
by: Anne Marie Kinn Rød, et al.
Published: (2017-07-01)